Peer-influenced content. Sources you trust. No registration required. This is HCN.
Epoch Health
Between 2019 and 2023, NDM-CRE infections, including pneumonia, bloodstream infections, urinary tract infections, and wound infections, surged by more than 460 percent in the United States.
Hospitalist October 9th 2025
Endocrinology Advisor
Gepotidacin demonstrated superiority to nitrofurantoin in the EAGLE-3 trial with a therapeutic success rate of 58.9% versus 44%, while maintaining a manageable side effect profile primarily consisting of gastrointestinal disturbances.
Family Medicine/General Practice May 7th 2025
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS